Anti-complement Agents for Autoimmune Neurological Disease-Reference-Cited by-同舟云学术

Anti-complement Agents for Autoimmune Neurological Disease

Published:2022-04 Issue:3 Volume:19 Page:711-728
ISSN:1933-7213
Container-title:Neurotherapeutics
language:en
Short-container-title:Neurotherapeutics

Author:

McCombe Jennifer A.,Pittock Sean J.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s13311-022-01223-w.pdf

Reference94 articles.

1. Sechi E, Flanagan EP. Antibody-mediated autoimmune diseases of the CNS: challenges and approaches to diagnosis and management. Front Neurol. 2021;12:673339.

2. Pittock SJ, Zekeridou A, Weinshenker BG. New hope for patients with neuromyelitis optica: From biomarker discovery to completion of phase 3 trials. Submitted. 2022.

3. Tintore M, Vidal-Jordana A, Sastre-Garriga J. Treatment of multiple sclerosis - success from bench to bedside. Nat Rev Neurol. 2019;15(1):53–8.

4. Lublin F. History of modern multiple sclerosis therapy. J Neurol. 2005;252(Suppl 3):iii3–9.

5. Olsson T. Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma. J Neuroimmunol. 1992;40(2–3):211–8.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paraneoplastic/autoimmune myelopathies;Handbook of Clinical Neurology;2024

2. Neuromyelitis optica spectrum disorder and other central nervous system inflammatory diseases;The Rose and Mackay Textbook of Autoimmune Diseases;2024

3. Neuromyelitis Optica: Pathogenesis Overlap with Other Autoimmune Diseases;Current Allergy and Asthma Reports;2023-10-27

4. Eculizumab for the treatment of glycine receptor antibody associated stiff-person syndrome;Journal of Neurology;2023-05-18

5. Therapeutic Antibodies in Neurological Diseases: Witnessing the Continuation of the Impressive Success in Neuro-Immunotherapies;Neurotherapeutics;2022-04